Research on semaglutide and tirzepatide shows that lean mass can account for a meaningful portion of total weight lost, although fat mass still makes up the majority of the reduction
Over the past few decades, the incidence of obesity has been on the rise, and is currently a global pandemic affecting millions of people around the world
Discover a science-backed solution with our medical appetite suppressant programs designed for long-term results
Especially in view of the frequent adverse effects leading to discontinuation, more knowledge on efficacy, safety, and tolerability is surely needed before their introduction in the clinical practice against T2D or obesity
What happens when you miss a dose You will miss a dose eventually
Cardiovascular benefits have been demonstrated in clinical trials, with specific agents showing reductions in major adverse cardiovascular events